for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover Journal of Arrhythmia
  [SJR: 0.119]   [H-I: 2]   [0 followers]  Follow
  This is an Open Access Journal Open Access journal
   ISSN (Print) 1880-4276 - ISSN (Online) 1883-2148
   Published by Elsevier Homepage  [2970 journals]
  • Editorial Board

    • Citation: Journal of Arrhythmia 32, 2 (2016)
      PubDate: 2016-04
      DOI: 10.1016/S1880-4276(16)30012-6
      Issue No: Vol. 32, No. 2 (2016)
  • Risk factors for amiodarone-induced thyroid dysfunction in Japan

    • Authors: Sayoko Kinoshita; Tomohiro Hayashi, Kyoichi Wada, Mikie Yamato, Takeshi Kuwahara, Toshihisa Anzai, Mai Fujimoto, Kouichi Hosomi, Mitsutaka Takada
      Abstract: Amiodarone is associated with a number of significant adverse effects, including elevated transaminase levels, pulmonary fibrosis, arrhythmia, and thyroid dysfunction. Although thyroid dysfunction is considered to be a common and potentially serious adverse effect of amiodarone therapy, the exact pathogenesis remains unknown because of its complex manifestations. Therefore, the prevalence of, and risk factors for, amiodarone-induced thyroid dysfunction in Japanese patients were investigated in the present study.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-05-04
      DOI: 10.1016/j.joa.2016.03.008
  • Trends and determinant factors in the use of cardiac resynchronization
           therapy devices in Japan: Analysis of the Japan cardiac device treatment
           registry database

    • Authors: Hisashi Yokoshiki; Akihiko Shimizu, Takeshi Mitsuhashi, Hiroshi Furushima, Yukio Sekiguchi, Tetsuyuki Manaka, Nobuhiro Nishii, Takeshi Ueyama, Norishige Morita, Takashi Nitta, Ken Okumura, Members of the Implantable Cardioverter-Defibrillator (ICD) Committee of the Japanese Heart Rhythm Society
      Abstract: The choice of cardiac resynchronization therapy device, with (CRT-D) or without (CRT-P) a defibrillator, in patients with heart failure largely depends on the physician׳s discretion, because it has not been established which subjects benefit most from a defibrillator.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-04-29
      DOI: 10.1016/j.joa.2016.04.002
  • The association between defibrillation shock energy and acute cardiac
           damage in patients with implantable cardioverter defibrillators

    • Authors: Daisuke Ishigaki; Daisuke Kutsuzawa, Takanori Arimoto, Tadateru Iwayama, Naoaki Hashimoto, Yu Kumagai, Satoshi Nishiyama, Hiroki Takahashi, Tetsuro Shishido, Takuya Miyamoto, Joji Nitobe, Akio Fukui, Tetsu Watanabe, Isao Kubota
      Abstract: The aim of this study was to establish a minimally invasive defibrillation testing (DT) protocol for patients with implantable cardioverter defibrillators (ICDs).
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-04-26
      DOI: 10.1016/j.joa.2016.03.007
  • Temporal sinus node modification by high-dose continuous intravenous
           administration of landiolol in a patient with persistent inappropriate
           sinus tachycardia

    • Authors: Yuichi Hori; Shiro Nakahara, Naofumi Anjo, Yoshihiko Sakai, Isao Taguchi
      Abstract: A 20-year-old woman underwent an electrophysiological study for drug-resistant persistent inappropriate sinus tachycardia (IST). Use of a high-dose continuous intravenous administration of landiolol, a short-acting beta-adrenoreceptor blocker, made the patient׳s heart rate suddenly drop with a slight change in the P-wave morphology. Three-dimensional right atrial (RA) activation mapping revealed that the earliest activation site moved 8mm to a lower anterior site around the high lateral RA. Radiofrequency energy applied to the earliest activation site during tachycardia was successful.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-04-25
      DOI: 10.1016/j.joa.2016.03.003
  • Atriofascicular pathway detection with novel ablation catheter

    • Authors: Padmanabhan Shakkottai; Adrian Baranchuk, Neil Hobson, Jane Caldwell
      Abstract: Atriofascicular pathways are a rare cause of antidromic atrioventricular reciprocating tachycardia. The IntellaTip MiFi ablation catheter (Boston Scientific, MA, USA) is a novel ablation catheter that allows enhanced signal clarity with highly localized electrograms. This is the first report of this catheter being successfully used to map and ablate the atriofascicular pathway potentials.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-04-25
      DOI: 10.1016/j.joa.2016.03.006
  • Successful cryoballoon pulmonary vein isolation in a patient with situs
           inversus and dextrocardia

    • Authors: Yasuhiro Yoshiga; Akihiko Shimizu, Takeshi Ueyama, Makoto Ono, Tomoko Fumimoto, Hironori Ishiguchi, Masafumi Yano
      Abstract: A 79-year-old man with situs inversus and dextrocardia underwent catheter ablation of symptomatic paroxysmal atrial fibrillation. Pulmonary vein isolation (PVI), using second-generation cryoballoon under Ensite NavX system guidance, was performed successfully in a reverse manner, which required short procedure and fluoroscopy times, as required in a PVI performed on a normal heart without any complications. Cryoballoon-based PVI under Ensite NavX guidance was feasible and safe to achieve a favorable outcome in this patient with abnormal anatomy.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-04-22
      DOI: 10.1016/j.joa.2016.03.005
  • Impact of catheter ablation of ventricular tachycardia in patients with
           prior myocardial infarctions

    • Authors: Masato Fukunaga; Masahiko Goya, Kenichi Hiroshima, Kentaro Hayashi, Masatsugu Ohe, Yu Makihara, Michio Nagashima, Yoshimori An, Shinichi Shirai, Kenji Ando, Hiroyoshi Yokoi, Masashi Iwabuchi
      Abstract: Catheter ablation can reduce episodes of ventricular tachycardia (VT) after myocardial infarction (MI). However, the optimal endpoint of the ablation procedure remains unclear.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-04-20
      DOI: 10.1016/j.joa.2016.03.001
  • Catheter ablation of anteroseptal accessory pathways from the aortic
           cusps: A case series and a review of the literature

    • Authors: Konstantinos P. Letsas; Michael Efremidis, Konstantinos Vlachos, Stamatis Georgopoulos, Nikolaos Karamichalakis, Athanasios Saplaouras, Sotirios Xydonas, Kosmas Valkanas, Antonios Sideris
      Abstract: Data regarding catheter ablation of anteroseptal accessory pathways through the aortic cusps are limited. We describe two cases of true para-Hisian accessory pathways successfully ablated from the aortic cusps (right coronary cusp and non-coronary cusp, respectively) along with a review of the current literature. Due to the close proximity to the atrioventricular node and the high risk of complication, mapping of the aortic cusps should always be considered in the case of anteroseptal accessory pathways.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-04-19
      DOI: 10.1016/j.joa.2016.02.010
  • Is it truly atrial tachycardia'

    • Authors: Yoshiaki Kaneko; Fumio Suzuki
      Abstract: We read the article by Okumura et al. [1] with great interest. The authors reported an ablation strategy applying manifest entrainment to treat adenosine triphosphate (ATP)-sensitive atrial tachycardia (AT) originating from the perinodal region. However, we have some concerns regarding the electrophysiological diagnosis of the tachycardia. The exclusion of atrioventricular nodal reentrant tachycardia (AVNRT) is essentially a prerequisite to diagnose AT. The authors excluded AVNRT based on the findings of atrioventricular dissociation during the ventricular pacing of tachycardia and a V–A–A–V activation sequence on ventricular induction of tachycardia.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-04-13
      DOI: 10.1016/j.joa.2016.03.002
  • Efficacy of atorvastatin in prevention of atrial fibrillation after heart
           valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial
           Fibrillation After Cardiac surgEry)

    • Authors: Yolanda Carrascal; Roman J. Arnold, Luis De la Fuente, Ana Revilla, Teresa Sevilla, Nuria Arce, Gregorio Laguna, Pilar Pareja, Miriam Blanco
      Abstract: To evaluate the efficacy of perioperative atorvastatin administration for prophylaxis of postoperative atrial fibrillation (POAF) after heart valve surgery.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-28
      DOI: 10.1016/j.joa.2016.01.010
  • Cardiac dynamics: Alternans and arrhythmogenesis

    • Authors: Gary Tse; Sheung Ting Wong, Vivian Tse, Yee Ting Lee, Hiu Yu Lin, Jie Ming Yeo
      Abstract: Pre-existing heterogeneities present in cardiac tissue are essential for maintaining the normal electrical and mechanical functions of the heart. Exacerbation of such heterogeneities or the emergence of dynamic factors can produce repolarization alternans, which are beat-to-beat alternations in the action potential time course. Traditionally, this was explained by restitution, but additional factors, such as cardiac memory, calcium handling dynamics, refractory period restitution, and mechano-electric feedback, are increasingly recognized as the underlying causes.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-28
      DOI: 10.1016/j.joa.2016.02.009
  • Lead extractions in patients with cardiac implantable electronic device
           infections: Single center experience

    • Authors: Masahiko Goya; Michio Nagashima, Ken-ichi Hiroshima, Kentaro Hayashi, Yu Makihara, Masato Fukunaga, Yoshimori An, Masatsugu Ohe, So-ichiro Yamazato, Ko-ichiro Sonoda, Kennosuke Yamashita, Kouji Katayama, Tomoaki Ito, Harushi Niu, Kenji Ando, Hiroyoshi Yokoi, Masashi Iwabuchi
      Abstract: Lead extraction using laser sheaths is performed mainly for cardiac implantable electronic device (CIED) infections. However, there are few reports concerning the management of CIED infections in Japan.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-22
      DOI: 10.1016/j.joa.2016.02.004
  • Double twiddle trouble, a new variant of twiddler syndrome

    • Authors: Aldo G. Carrizo; Paul S.G. Hong, Guy Amit, Jeff S. Healey
      Abstract: The twiddler syndrome results in retraction and coiling of the lead in the pacemaker pocket with subsequent pacemaker malfunction. If the lead׳s parameters are not affected, then the problem can be corrected by lead repositioning. We describe the first reported case of a dramatic pacemaker lead coiling with a double level of lead compromise, with one of them being intra-cardiac. This condition affected our treatment strategy, as the repositioning of the lead was unfeasible.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-21
      DOI: 10.1016/j.joa.2016.02.008
  • New horizon for infection prevention technology and implantable device

    • Authors: Yusuke Kondo; Marehiko Ueda, Yoshio Kobayashi, Joerg O. Schwab
      Abstract: There has been a significant increase in the number of patients receiving cardiovascular implantable electronic devices (CIED) over the last two decades. CIED infection represents a serious complication after CIED implantation and is associated with significant morbidity and mortality. Recently, newly advanced technologies have offered attractive and suitable therapeutic alternatives. Notably, the leadless pacemaker and anti-bacterial envelope decrease the potential risk of CIED infection and the resulting mortality, when it does occur.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-19
      DOI: 10.1016/j.joa.2016.02.007
  • ST elevation without cardio-pulmonary symptoms

    • Authors: Priyank Shah; Rahul Vasudev, Fayez Shamoon
      Abstract: A 57-year-old man with no significant past medical history presented to the emergency department (ED) with complaints of dysuria, increased frequency of urination, and subjective fevers since 2 days. The patient denied any other symptoms. He did not have any chest pain, dyspnea, orthopnea, paroxysmal nocturnal dyspnea, dizziness, or palpitations. At the time of presentation, the patient did not have a history of syncope or seizures. He worked in construction and could tolerate exercise without dyspnea.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-17
      DOI: 10.1016/j.joa.2016.01.008
  • The feasibility of a Box isolation strategy for non-paroxysmal atrial
           fibrillation in elderly patients

    • Authors: Satoshi Higuchi; Hiroshi Sohara, Yoshinori Nakamura, Minoru Ihara, Yoshio Yamaguchi, Morio Shoda, Nobuhisa Hagiwara, Shutaro Satake
      Abstract: Catheter ablation of non-paroxysmal atrial fibrillation (non-PAF) is a therapeutic challenge especially in elderly patients. This study describes the feasibility of a posterior left atrium isolation as a substrate modification in addition to pulmonary vein isolation, the so-called Box isolation, for elderly patients with non-PAF.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-15
      DOI: 10.1016/j.joa.2016.02.002
  • Clinical and genetic features of Australian families with long QT
           syndrome: A registry-based study

    • Authors: Charlotte Burns; Jodie Ingles, Andrew M. Davis, Vanessa Connell, Belinda Gray, Lauren Hunt, Julie McGaughran, Christopher Semsarian
      Abstract: Familial long QT syndrome (LQTS) is a primary arrhythmogenic disorder caused by mutations in ion channel genes. The phenotype ranges from asymptomatic individuals to sudden cardiac arrest and death. LQTS is a rare but significant health problem for which global data should exist. This study sought to provide the first clinical and genetic description of Australian families with LQTS.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-15
      DOI: 10.1016/j.joa.2016.02.001
  • Resolution of a warfarin and dabigatran-resistant left atrial appendage
           thrombus with apixaban

    • Authors: Yosuke Miwa; Toshinori Minamishima, Toshiaki Sato, Konomi Sakata, Hideaki Yoshino, Kyoko Soejima
      Abstract: The majority of embolisms associated with atrial fibrillation (AF) are from the left atrial appendage (LAA). To treat the existing thrombus, warfarin and novel anticoagulants have been used. However, there has been no clinical information regarding the difference of the effects of congealing the fibrinogenolysis system among these oral anticoagulants. Here, we report a case of persistent AF, in whom apixaban, factor Xa inhibitor resolved an LAA clot refractory to warfarin and direct thrombin inhibition.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-15
      DOI: 10.1016/j.joa.2016.01.009
  • Efficacy of atrial substrate modification based on dominant frequency of
           paroxysmal atrial fibrillation

    • Authors: Koji Kumagai; Kentaro Minami, Daisuke Kutsuzawa, Shigeru Oshima
      Abstract: The endpoint of ablation procedures is suggested to be non-inducibility of paroxysmal atrial fibrillation (PAF). However, the prognosis of induced AF/atrial tachycardia (AT) after pulmonary vein isolation (PVI) in PAF patients remains unclear.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-14
      DOI: 10.1016/j.joa.2016.02.005
  • Anti-arrhythmic medications increase non-cardiac mortality – A
           meta-analysis of randomized control trials

    • Authors: Bhavi Pandya; Jonathan Spagnola, Azfar Sheikh, Boutros Karam, Viswajit Reddy Anugu, Asif Khan, James Lafferty, David Kenigsberg, Marcin Kowalski
      Abstract: Anti-arrhythmic medications (AAMs) are known to increase cardiac mortality significantly due to their pro-arrhythmic effects. However, the effect of AAMs on non-cardiac mortality has not been evaluated.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-03-11
      DOI: 10.1016/j.joa.2016.02.006
  • The genetic background of arrhythmogenic right ventricular cardiomyopathy

    • Authors: Seiko Ohno
      Abstract: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by degeneration of the right ventricle and ventricular tachycardia originating from the right ventricle. Additionally, the disease is an inherited cardiomyopathy that mainly follows the autosomal dominant pattern. More than 10 genes have been reported as causative genes for ARVC, and more than half of ARVC patients carry mutations in desmosome related genes. The desmosome is one of the structures involved in cell adhesion and its disruption leads to various diseases, including a skin disease called pemphigus.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-24
      DOI: 10.1016/j.joa.2016.01.006
  • Eccentric scar formation around a pulmonary vein after cryo-balloon
           ablation in a patient with atrial fibrillation: A case report

    • Authors: Kunihiko Kiuchi; Koji Fukuzawa, Akinori Matsumoto
      Abstract: The impact of a cryoballoon ablation is reported to be similar to that of a radiofrequency (RF) ablation in patients with atrial fibrillation. Delayed enhancement magnetic resonance imaging (DE-MRI) could visualize the scar region induced by the cryoballoon ablation as well as RF ablation. Cryoballoon ablation could induce extensive scar lesions around the PVs. However, the distribution of the scar lesions after the cryoballoon ablation has not been well discussed. We, herein, described a case with an eccentric scar distribution after cryoballoon ablation.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-23
      DOI: 10.1016/j.joa.2016.01.007
  • Intermuscular pocket for subcutaneous implantable cardioverter
           defibrillator: Single-center experience

    • Abstract: The subcutaneous implantable cardioverter defibrillator (S-ICD) is a novel device now accepted in clinical practice for treating ventricular arrhythmias. In 14 consecutive patients, S-ICD devices were placed in the virtual space between the anterior surface of the serratus anterior muscle and the posterior surface of the latissimus dorsi muscle. During a mean follow up of 9 months, no dislocations, infections, hematoma formations, or skin erosions were observed. Intermuscular implantation of the S-ICD could be a reliable, safe, and appealing alternative to the standard subcutaneous placement.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-23
      DOI: 10.1016/j.joa.2016.01.005
  • Radiofrequency catheter ablation of left-sided accessory pathways via
           retrograde aortic approach in children

    • Abstract: We aimed to analyze the results of retrograde aortic radiofrequency catheter ablation of left-sided accessory pathways in children.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-11
      DOI: 10.1016/j.joa.2015.12.007
  • A multicenter observational study of the effectiveness of antiarrhythmic
           agents in ventricular arrhythmias: A propensity-score adjusted analysis

    • Authors: Makoto Suzuki; Wataru Nagahori, Akira Mizukami, Akihiko Matsumura, Yuji Hashimoto
      Abstract: Ventricular tachyarrhythmias (VTs) are life-threatening events that result in hemodynamic compromise. Recurrence is common and may worsen a patient׳s clinical course despite appropriate treatment. This study aimed to examine the effectiveness of antiarrhythmic drugs for suppression of VTs.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-10
      DOI: 10.1016/j.joa.2016.01.004
  • Atrial arrhythmias in inherited arrhythmogenic disorders

    • Authors: Can Hasdemir
      Abstract: Atrial arrhythmias are being increasingly recognized in inherited arrhythmogenic disorders particularly in patients with Brugada syndrome and short QT syndrome. Atrial arrhythmias in inherited arrhythmogenic disorders have significant epidemiologic, clinical, and prognostic implications. There has been progress in the understanding of underlying genetic characteristics and the mechanistic link between atrial arrhythmias and inherited arrhythmogenic disorders. Appropriate management of these patients is of paramount importance.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-09
      DOI: 10.1016/j.joa.2015.11.007
  • Alternative approach for management of an electrical storm in Brugada
           syndrome:Importance of primary ablation within a narrow time window

    • Authors: Ahmed Karim Talib; Yoshiaki Yui, Takashi Kaneshiro, Yukio Sekiguchi, Akihiko Nogami, Kazutaka Aonuma
      Abstract: Placement of an implantable cardioverter–defibrillator (ICD) is the only powerful treatment modality for Brugada syndrome in patients presenting with ventricular fibrillation (VF). For those whose first presentation is an electrical storm, pharmacologic therapy is typically used to control VF followed by ICD implantation. We report an alternative approach whereby, before ICD implantation, emergency catheter ablation of the VF-triggering premature ventricular contraction (PVC) resulted in long-term VF-free survival.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-08
      DOI: 10.1016/j.joa.2015.12.008
  • Successful dual chamber ICD implantation via a persistent left superior
           vena cava after ratchet syndrome

    • Authors: Naofumi Anjo; Shiro Nakahara, Tohru Kamijima, Yuichi Hori, Ayako Nakagawa, Naoki Nishiyama, Kouta Yamada, Takaaki Komatsu, Sayuki Kobayashi, Yoshihiko Sakai, Isao Taguchi
      Abstract: Device implantations may be challenging in patients with venous abnormalities. The most common congenital variation, frequently associated with other congenital abnormalities, is a persistent left superior vena cava (PLSVC), and successful atrial and ventricular lead implantation via a PLSVC have both been reported [1].
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-06
      DOI: 10.1016/j.joa.2016.01.003
  • Recent advances in genetic testing and counseling for inherited

    • Authors: Yuka Mizusawa
      Abstract: Inherited arrhythmias, such as cardiomyopathies and cardiac ion channelopathies, along with coronary heart disease (CHD) are three most common disorders that predispose adults to sudden cardiac death. In the last three decades, causal genes in inherited arrhythmias have been successfully identified. At the same time, it has become evident that the genetic architectures are more complex than previously known. Recent advancements in DNA sequencing technology (next generation sequencing) have enabled us to study such complex genetic traits.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-05
      DOI: 10.1016/j.joa.2015.12.009
  • Clinical and electrocardiographic predictors of T wave oversensing in
           patients with subcutaneous ICD

    • Authors: Mikhael F. El-Chami; Bernard Harbieh, Mathew Levy, Angel R. Leon, Faisal M. Merchant
      Abstract: T wave oversensing (TWOS) is a major drawback of the subcutaneous implantable cardioverter defibrillator (S-ICD). Data on predictors of TWOS in S-ICD recipients are limited.We sought to investigate predictors of TWOS in a cohort of patients receiving an S-ICD at our institution.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-05
      DOI: 10.1016/j.joa.2016.01.002
  • Histological examination of the right atrial appendage after failed
           catheter ablation for focal atrial tachycardia complicated by cardiogenic
           shock in a post-partum patient

    • Authors: Akira Mizukami; Makoto Suzuki, Rena Nakamura, Shunsuke Kuroda, Maki Ono, Yuya Matsue, Ryota Iwatsuka, Taishi Yonetsu, Akihiko Matsumura, Yuji Hashimoto
      Abstract: A 26-year-old woman in her first pregnancy presented with persistent atrial tachycardia (AT). AT was resistant to medications, cardioversions, and the first attempt of catheter ablation. Two months after delivery she developed severe systolic dysfunction and circulatory collapse. Emergent catheter ablation was performed with the support of percutaneous cardiopulmonary bypass and intraaortic balloon pump. The AT originated in the apex of the right atrial appendage (RAA). Repeated attempts at ablation were unsuccessful, prompting surgical RAA resection, which terminated the tachycardia and improved the cardiac function.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-03
      DOI: 10.1016/j.joa.2016.01.001
  • Impact of transesophageal echocardiography during transseptal puncture on
           atrial fibrillation ablation

    • Abstract: The aim of our study was to demonstrate the added value of routine transesophageal echocardiography (TEE) for correctly positioning the transseptal system in the fossa ovalis (FO), thus potentially preventing complications during fluoroscopy-guided transseptal puncture (TP), and for assessing the optimal puncture site within the FO according to the expected procedure type.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-01-28
      DOI: 10.1016/j.joa.2015.12.005
  • Molecular pathogenesis of long QT syndrome type 1

    • Authors: Jie Wu; Wei-Guang Ding, Minoru Horie
      Abstract: Long QT syndrome type 1 (LQT1) is a subtype of a congenital cardiac syndrome caused by mutation in the KCNQ1 gene, which encodes the α-subunit of the slow component of delayed rectifier K+ current (IKs) channel. Arrhythmias in LQT1 are characterized by prolongation of the QT interval on ECG, as well as the occurrence of life-threatening cardiac events, frequently triggered by adrenergic stimuli (e.g., physical or emotional stress). During the past two decades, much advancement has been made in understanding the molecular pathogenesis underlying LQT1.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-01-27
      DOI: 10.1016/j.joa.2015.12.006
  • Home monitoring report from a single lead Lumax DX implantable
           cardioverter defibrillator: New observations in a new system

    • Authors: Yuval Konstantino; Alex Kleiman, Guy Amit
      Abstract: A 56-year-old man underwent a single lead Lumax 640 DX implantable cardioverter defibrillator implantation for primary prevention of sudden cardiac death. A DX system consists of a single lead, which provides atrial as well as ventricular electrograms, and enhances atrial arrhythmia detection. Three months after the implantation, high-frequency episodes were detected on the far field and the atrial channels, but not on the bipolar right ventricular channel; these were classified as atrial tachycardia.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-01-25
      DOI: 10.1016/j.joa.2015.12.004
  • Molecular pathogenesis of long QT syndrome type 2

    • Authors: Jennifer L. Smith; Corey L. Anderson, Don E. Burgess, Claude S. Elayi, Craig T. January, Brian P. Delisle
      Abstract: The molecular mechanisms underlying congenital long QT syndrome (LQTS) are now beginning to be understood. New insights into the etiology and therapeutic strategies are emerging from heterologous expression studies of LQTS-linked mutant proteins, as well as inducible pluripotent stem cell derived cardiomyocytes (iPSC-CMs) from LQTS patients. This review focuses on the major molecular mechanism that underlies LQTS type 2 (LQT2). LQT2 is caused by loss of function (LOF) mutations in KCNH2 (also known as the human Ether-à-go-go-Related Gene or hERG).
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-01-22
      DOI: 10.1016/j.joa.2015.11.009
  • Letter to the Editor: Marino et al. Inappropriate mode switching clarified
           by using a chest radiograph

    • Authors: Mohammad Ali Akbarzadeh
      Abstract: To the Editor,
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-01-19
      DOI: 10.1016/j.joa.2015.12.002
  • Management of antithrombotic therapy during cardiac implantable device

    • Authors: Ahmed AlTurki; Riccardo Proietti, David H. Birnie, Vidal Essebag
      Abstract: Anticoagulants are commonly used drugs that are frequently encountered during device placement. Deciding when to halt or continue the use of anticoagulants is a balance between the risks of thromboembolism versus bleeding. Patients taking warfarin with a high risk of thromboembolism should continue to take their warfarin without interruption during device placement while ensuring their international normalized ratio remains below 3. For patients who are taking warfarin and have low risk of thromboembolism, either interrupted or continued warfarin may be used, with no evidence to clearly support either strategy.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-01-18
      DOI: 10.1016/j.joa.2015.12.003
  • Usefulness of combined CARTO electroanatomical mapping and manifest
           entrainment in ablating adenosine triphosphate-sensitive atrial
           tachycardia originating from the atrioventricular node vicinity

    • Authors: Ken Okumura; Shingo Sasaki, Masaomi Kimura, Daisuke Horiuchi, Kenichi Sasaki, Taihei Itoh, Hirofumi Tomita, Yuji Ishida, Takahiko Kinjo
      First page: 133
      Abstract: By using a noncontact mapping system, adenosine triphosphate (ATP)-sensitive atrial tachycardia (ATP-AT) originating from the atrioventricular (AV) node vicinity was successfully ablated at the entrance to the slow conduction zone indicated by the manifest entrainment technique. We aimed to prospectively validate the efficacy of the combination of CARTO electroanatomical mapping and manifest entrainment in ablating this ATP-AT.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-01-13
      DOI: 10.1016/j.joa.2015.11.004
  • Localized rotors and focal impulse sources within the left atrium in human
           atrial fibrillation: A phase analysis of contact basket catheter

    • Authors: Naoko Sasaki; Yasuo Okumura, Ichiro Watanabe, Andrew Madry, Yuki Hamano, Mizuki Nikaido, Rikitake Kogawa, Koichi Nagashima, Keiko Takahashi, Kazuki Iso, Kimie Ohkubo, Toshiko Nakai, Atsushi Hirayama
      First page: 141
      Abstract: Consistent detection of rotor(s) and/or focal impulse(s) of atrial fibrillation can using a 64-pole basket catheter remain unclear.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-03
      DOI: 10.1016/j.joa.2015.11.010
  • Post-marketing surveillance on the long-term use of dabigatran in Japanese
           patients with nonvalvular atrial fibrillation: Preliminary report of the
           J-dabigatran surveillance

    • Authors: Hiroshi Inoue; Shinichiro Uchiyama, Hirotsugu Atarashi, Ken Okumura, Yukihiro Koretsune, Masahiro Yasaka, Takeshi Yamashita, Makiko Ohnishi, Nobutaka Yagi, Taku Fukaya, for the J-Dabigatran Surveillance Investigators
      First page: 145
      Abstract: A post-marketing surveillance (PMS) study is being conducted to investigate the safety and effectiveness of the long-term use of dabigatran etexilate (dabigatran) in Japanese patients with nonvalvular atrial fibrillation (NVAF). Results of an interim analysis of this prospective cohort study including patient characteristics and adverse drug reactions (ADRs) collected up to September 17, 2014 are reported here.
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-01-16
      DOI: 10.1016/j.joa.2015.11.008
  • Ischemic Brugada phenocopy during ablation of ventricular tachycardia

    • Authors: Byron H. Gottschalk; Daniel D. Anselm, Adrian Baranchuk
      First page: 156
      Abstract: We examined the report by Hori et al. with specific interest in their description of a Brugada ECG (electrocardiogram) pattern observed during ablation of ventricular tachycardia (VT) [1]. Their case provides an important contribution to an expanding database of ischemic Brugada phenocopies (BrP) [2,3].
      Citation: Journal of Arrhythmia (2016)
      PubDate: 2016-02-09
      DOI: 10.1016/j.joa.2015.11.002
  • Characterization of the novel mutant A78T-HERG from a long QT syndrome
           type 2 patient: Instability of the mutant protein and stabilization by
           heat shock factor 1

    • Authors: Takehito Kondo; Ichiro Hisatome, Shouichi Yoshimura, Endang Mahati, Tomomi Notsu, Peili Li, Kazuhiko Iitsuka, Masaru Kato, Kazuyoshi Ogura, Junichiro Miake, Takeshi Aiba, Wataru Shimizu, Yasutaka Kurata, Shinji Sakata, Naoe Nakasone, Haruaki Ninomiya, Akira Nakai, Katsumi Higaki, Yasushi Kawata, Yasuaki Shirayoshi, Akio Yoshida, Kazuhiro Yamamoto
      Abstract: The human ether-a-go-go-related gene (HERG) encodes the α-subunit of rapidly activating delayed-rectifier potassium channels. Mutations in this gene cause long QT syndrome type 2 (LQT2). In most cases, mutations reduce the stability of the channel protein, which can be restored by heat shock (HS).
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-24
  • Current topics in catecholaminergic polymorphic ventricular tachycardia

    • Authors: Naokata Sumitomo
      Abstract: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is induced by emotions or exercise in patients without organic heart disease and may be polymorphic or bidirectional in nature. The prognosis of CPVT is not good, and therefore prevention of sudden death is of utmost importance. Genetic variants of CPVT include RyR2, CASQ2, CALM2, TRD, and possibly KCNJ2 and ANK2 gene mutations. Hypotheses that suggest the causes of CPVT include weakened binding of FKBP12.6 and RyR2, a store overload-induced Ca2+ release (SOICR), unzipping of intramolecular domain interactions in RyR2, and molecular and functional abnormalities caused by mutations in the CASQ2 gene.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-24
      DOI: 10.1016/j.joa.2015.09.008
  • Conservative therapy for the management of cardiac implantable electronic
           device infection

    • Authors: Yukio Sekiguchi
      Abstract: Along with the increased frequency of implantation, the incidence of cardiac implantable electronic device (CIED) infection, which can have serious or fatal complications, has also increased. Although several successful conservative therapies for CIED infection have been reported, retained infected devices remain a source of relapse, which is closely related to a higher mortality rate. Presently, complete hardware removal is initially recommended for infected CIED patients, and indications for conservative therapy, including continuous administration of antibiotics, require careful consideration.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-19
      DOI: 10.1016/j.joa.2015.09.012
  • Molecular autopsy in victims of inherited arrhythmias

    • Authors: Christopher Semsarian; Jodie Ingles
      Abstract: Sudden cardiac death (SCD) is a rare but devastating complication of a number of underlying cardiovascular diseases. While coronary artery disease and acute myocardial infarction are the most common causes of SCD in older populations, inherited cardiac disorders comprise a substantial proportion of SCD cases aged less than 40 years. Inherited cardiac disorders include primary inherited arrhythmogenic disorders such as familial long QT syndrome (LQTS), Brugada syndrome (BrS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and inherited cardiomyopathies, most commonly hypertrophic cardiomyopathy (HCM).
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-19
      DOI: 10.1016/j.joa.2015.09.010
  • Inherited bradyarrhythmia: A diverse genetic background

    • Authors: Taisuke Ishikawa; Yukiomi Tsuji, Naomasa Makita
      Abstract: Bradyarrhythmia is a common heart rhythm abnormality comprising number of diseases and is associated with decreased heart rate due to the failure of action potential generation and propagation at the sinus node. Permanent pacemaker implantation is often used therapeutically to compensate for decreased heart rate and cardiac output. The vast majority of bradyarrhythmia cases are attributable either to aging or to structural abnormalities of the cardiac conduction system, caused by underlying structural heart disease.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-19
      DOI: 10.1016/j.joa.2015.09.009
  • Incidence of cardiac implantable electronic device infections and
           migrations in Japan: Results from a 129 institute survey

    • Authors: Hiroshi Nakajima; Masami Taki
      Abstract: We conducted a survey of the infection burden associated with the implantation of cardiac implantable electronic devices (CIEDs) in Japan.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-04
      DOI: 10.1016/j.joa.2015.09.006
  • Autonomic and cardio-respiratory responses to exercise in Brugada Syndrome

    • Authors: Raoyrin Chanavirut; Pattarapong Makarawate, Ian A. Macdonald, Naruemon Leelayuwat
      Abstract: Imbalances of the autonomic nervous (ANS), the cardiovascular system, and ionics might contribute to the manifestation of The Brugada Syndrome (BrS). Thus, this study has aimed to investigate the cardio-respiratory fitness and the responses of the ANS both at rest and during a sub-maximal exercise stress test, in BrS patients and in gender-matched and age-matched healthy sedentary controls.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-10-29
      DOI: 10.1016/j.joa.2015.09.001
  • Left cardiac sympathetic denervation: An important treatment option for
           patients with hereditary ventricular arrhythmias

    • Authors: Yongkeun Cho
      Abstract: Medications such as ß-blockers are currently the primary treatment for patients with hereditary arrhythmia syndromes such as long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). However, these drugs are ineffective in some patients, and the other treatment option, that is implantable cardioverter defibrillator (ICD) implantation, is associated with significant complications in young and active patients. Left cardiac sympathetic denervation (LCSD) may reduce the wide gap between life-long ß-blocker medication and ICD implantation.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-10-29
      DOI: 10.1016/j.joa.2015.08.002
  • Arrhythmia management after device removal

    • Authors: Nobuhiro Nishii
      Abstract: Arrhythmic management is needed after removal of cardiac implantable electronic devices (CIEDs). Patients completely dependent on CIEDs need temporary device back-up until new CIEDs are implanted. Various methods are available for device back-up, and the appropriate management varies among patients. The duration from CIED removal to implantation of a new CIED also differs among patients. Temporary pacing is needed for patients with bradycardia, a wearable cardioverter defibrillator (WCD) or catheter ablation is needed for patients with tachyarrhythmia, and sequential pacing is needed for patients dependent on cardiac resynchronization therapy.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-10-23
      DOI: 10.1016/j.joa.2015.09.004
  • Lead extraction using a laser system: Techniques, efficacy, and

    • Authors: Hideo Okamura
      Abstract: Transvenous lead extraction is becoming popular in Japan since the approval of laser extraction system in 2010. The laser system seems to be the standard method used by most physicians, owing to its efficacy and ease of handling. The efficacy and safety of this technology has been well proven in many studies and the data suggest that it can be used for Japanese patients safely. However, lead extraction can cause serious complications. Thus, it is important to learn the limitations as well as the basic techniques and efficacy of this procedure.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-08-18
      DOI: 10.1016/j.joa.2015.06.006
  • Perioperative management for the prevention of bacterial infection in
           cardiac implantable electronic device placement

    • Authors: Katsuhiko Imai
      Abstract: Cardiac implantable electronic devices (CIEDs) have become important in the treatment of cardiac disease and placement rates increased significantly in the last decade. However, despite the use of appropriate antimicrobial prophylaxis, CIED infection rates are increasing disproportionately to the implantation rate. CIED infection often requires explantation of all hardware, and at times results in death. Surgical site infection (SSI) is the most common cause of CIED infection as a pocket infection.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-08-07
      DOI: 10.1016/j.joa.2015.06.007
  • Mechanisms of cardiac arrhythmias

    • Authors: Gary Tse
      First page: 75
      Abstract: Blood circulation is the result of the beating of the heart, which provides the mechanical force to pump oxygenated blood to, and deoxygenated blood away from, the peripheral tissues. This depends critically on the preceding electrical activation. Disruptions in the orderly pattern of this propagating cardiac excitation wave can lead to arrhythmias. Understanding of the mechanisms underlying their generation and maintenance requires knowledge of the ionic contributions to the cardiac action potential, which is discussed in the first part of this review.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-12-16
      DOI: 10.1016/j.joa.2015.11.003
  • Practical applicability of landiolol, an ultra-short-acting
           β1-selective blocker, for rapid atrial and ventricular
           tachyarrhythmias with left ventricular dysfunction

    • Authors: Yuko Wada; Takeshi Aiba, Yasuyuki Tsujita, Hideki Itoh, Mitsuru Wada, Ikutaro Nakajima, Kohei Ishibashi, Hideo Okamura, Koji Miyamoto, Takashi Noda, Yasuo Sugano, Hideaki Kanzaki, Toshihisa Anzai, Kengo Kusano, Satoshi Yasuda, Minoru Horie, Hisao Ogawa
      First page: 82
      Abstract: Landiolol effectively controls rapid heart rate in atrial fibrillation or flutter (AF/AFL) patients with left ventricular (LV) dysfunction. However, predicting landiolol Responders and Non-Responders and patients who will experience adverse effects remains a challenge. The aim of this study was to clarify the potential applicability of landiolol for rapid AF/AFL and refractory ventricular tachyarrhythmias (VTs) in patients with heart failure.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-02
      DOI: 10.1016/j.joa.2015.09.002
  • Outcomes of single- or dual-chamber implantable cardioverter defibrillator
           systems in Japanese patients

    • Authors: Akiko Ueda; Yasushi Oginosawa, Kyoko Soejima, Haruhiko Abe, Ritsuko Kohno, Hisaharu Ohe, Yuichi Momose, Mika Nagaoka, Noriko Matsushita, Kyoko Hoshida, Yosuke Miwa, Mutsumi Miyakoshi, Ikuko Togashi, Akiko Maeda, Toshiaki Sato, Hideaki Yoshino
      First page: 89
      Abstract: There are no criteria for selecting single- or dual-chamber implantable cardioverter defibrillators (ICDs) in patients without a pacing indication. Recent reports showed no benefit of the dual-chamber system despite its preference in the United States. As data on ICD selection and respective outcomes in Japanese patients are scarce, we investigated trends regarding single- and dual-chamber ICD usage in Japan.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-12-10
      DOI: 10.1016/j.joa.2015.09.007
  • Initial experience and treatment of atrial fibrillation using a novel
           irrigated multielectrode catheter: Results from a prospective two-center

    • First page: 95
      Abstract: PV electrical isolation has become the cornerstone of catheter ablation for the treatment of atrial fibrillation (AF). Several strategies have been proposed to achieve this goal. The aim of this study was to assess the efficacy and safety of AF ablation using a new circular irrigated multielectrode ablation catheter designed to achieve single-delivery pulmonary vein (PV) isolation.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-24
      DOI: 10.1016/j.joa.2015.09.011
  • Influence of primary and secondary prevention indications on anxiety about
           the implantable cardioverter-defibrillator

    • Authors: Anita Rahmawati; Akiko Chishaki, Tomoko Ohkusa, Hiroyuki Sawatari, Miyuki Tsuchihashi-Makaya, Yuko Ohtsuka, Mori Nakai, Mami Miyazono, Nobuko Hashiguchi, Harumizu Sakurada, Masao Takemoto, Yasushi Mukai, Shujirou Inoue, Kenji Sunagawa, Hiroaki Chishaki
      First page: 102
      Abstract: Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-19
  • Usefulness of filtered unipolar electrogram morphology for evaluating
           transmurality of ablated lesions during pulmonary vein isolation

    • Authors: Rikitake Kogawa; Ichiro Watanabe, Yasuo Okumura, Hiroaki Mano, Kazumasa Sonoda, Koichi Nagashima, Naoko Sasaki, Kimie Ohkubo, Keiko Takahashi, Kazuki Iso, Sayaka Kurokawa, Toshiko Nakai, Atsushi Hirayama
      First page: 108
      Abstract: Although alteration of the amplitude and morphology of bipolar electrograms is used widely as a guide of the ablation effect, there is little information concerning unipolar electrograms. The amplitude and morphology of filtered bipolar (BP) and filtered unipolar (UP) electrograms were compared during pulmonary vein isolation in patients with atrial fibrillation.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-27
  • Translation and validation of the Malay version of the Stroke Knowledge

    • Authors: Siti Noorkhairina Sowtali; Dariah Mohd Yusoff, Sakinah Harith, Monniaty Mohamed
      First page: 112
      Abstract: To date, there is a lack of published studies on assessment tools to evaluate the effectiveness of stroke education programs.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-24
  • Combined catheter ablation for atrial fibrillation and Watchman® left
           atrial appendage occlusion procedures: Five-year experience

    • Authors: Karen P. Phillips; Daniel T. Walker, Julie A. Humphries
      First page: 119
      Abstract: Patients with atrial fibrillation (AF) may benefit from undergoing concomitant interventions of left atrial catheter ablation and device occlusion of the left atrial appendage (LAA) as a two-pronged strategy for rhythm control and stroke prevention. We report on the outcome of combined procedures in a single center case series over a 5-year timeframe.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-12-08
      DOI: 10.1016/j.joa.2015.11.001
  • Electrophysiological validation of total atrial conduction time
           measurement by tissue doppler echocardiography according to age and sex in
           healthy adults

    • First page: 127
      Abstract: We sought to validate total atrial conduction time (TACT) measurement via tissue Doppler imaging (TDI) by comparing the electrophysiological study (EPS) measurements of healthy subjects, according to age and sex.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-12-14
      DOI: 10.1016/j.joa.2015.11.006
  • A case report of successful permanent pacemaker implantation via the iliac

    • Authors: Tetsuo Yamaguchi; Takamichi Miyamoto, Yasuteru Yamauchi, Tohru Obayashi
      First page: 151
      Abstract: An 85-year-old man was referred to our hospital with a pacemaker pocket infection. A permanent pacemaker had been implanted via the right subclavian vein. The pacemaker and pacing leads were removed and a temporary pacemaker was implanted. After vancomycin treatment for 4 weeks, pacemaker implantation via the right external iliac vein was performed under local anesthesia because of left subclavian vein occlusion, infection of the right pocket, and difficulty with epicardial lead insertion. The iliac vein approach is an effective alternative in patients in whom the pectoral approach cannot be used.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-10-29
      DOI: 10.1016/j.joa.2015.08.004
  • Successful intraprocedural anticoagulation with bivalirudin during
           pulmonary vein isolation in a patient with known heparin-induced
           thrombocytopenia type II

    • Authors: Barbara Bellmann; Patrick Nagel, Bogdan G. Muntean
      First page: 154
      Abstract: We report the case of a 56-year-old female who presented with symptomatic paroxysmal atrial fibrillation. Anamnestic heparin-induced thrombocytopenia (HIT) type II was suspected, and a rapid diagnostic test showed antibodies against platelet factor 4. The heparin-induced platelet activation-assay was negative. Radiofrequency pulmonary vein isolation with intraprocedural anticoagulation using bivalirudin was ultimately performed. Dosing was controlled by monitoring the activated clotting time. Post-procedural blood tests were normal.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-11-19
  • Pseudofusion in a dual chamber pacemaker: Is this pacemaker working

    • Authors: Mohammad Ali Akbarzadeh; Abolfath Alizadeh, Negar Bahrololoumi Bafruee
      First page: 157
      Abstract: A 57-year-old woman with a history of dizziness due to episodes of complete heart block and bradycardia was referred to the electrophysiology ward for pacemaker implantation. A dual chamber pacemaker (Medtronic, Relia, Medtronic, Minneapolis, USA) was implanted. Its analysis showed normal function (atrial lead capture threshold 0.5V at 0.4ms, ventricular lead capture threshold 0.75V at 0.4ms, and P-wave and R wave amplitude sensing 2mV and 8mV, respectively). The pacemaker was programmed in the DDDR mode with a lower rate limit of 60bpm, atrial and ventricular output of 3.5V and 3.5V at 0.4ms respectively, atrial and ventricular sensitivity of 0.5mV and 2.8mV respectively, a paced atrioventricular interval (pAVI) of 180ms, and a sensed atrioventricular interval of 150ms.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-10-29
      DOI: 10.1016/j.joa.2015.09.003
  • Differential diagnostic dilemma between pulmonary embolism and acute
           coronary syndrome

    • Authors: Enes Elvin Gul; Kjell C. Nikus, Halil I. Erdogan, Kurtulus Ozdemir
      First page: 160
      Abstract: Acute pulmonary embolism (PE) is a frequent life-threatening condition in emergency departments. Careful diagnosis is important, and different diagnostic tests such as electrocardiogram (ECG), biochemical markers, echocardiogram, and computed tomography are required. Although ECG is a cheap and rapid diagnostic test for pulmonary embolism, it has some limitations in the differential diagnosis of acute coronary syndrome and acute PE. Herein, we report ECG results of a patient diagnosed with acute PE mimicking acute coronary syndrome.
      Citation: Journal of Arrhythmia (2015)
      PubDate: 2015-12-09
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015